The study’s authors also concluded that an analysis of full-fat dairy products, including cheese, indicated neither an increased risk nor a decreased risk of elevated blood pressure.
According to a new report from the Dairy Research Institute (Rosemont, IL), a meta-analysis published recently in the Journal of Human Hypertension states that consumption of low-fat dairy products may decrease the risk of elevated blood pressure. Moreover, regardless of fat content, fluid dairy products, such as low-fat and full-fat milk and yogurt, are associated with a reduced risk of elevated blood pressure.
“This latest review reinforces the value that dairy foods provide, by indicating that three servings of low-fat dairy products per day may help to reduce the risk of elevated blood pressure,” says Gregory Miller, PhD, president of the institute.
The study’s authors also concluded that an analysis of full-fat dairy products, including cheese, indicated neither an increased risk nor a decreased risk of elevated blood pressure.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.